Genomic Characteristics and the Potential Clinical Implications in Oligometastatic Non-Small Cell Lung Cancer.

Cancer Res Treat · 2023 · PMC10372584 · PMID 36634615

Europe PMC DOI

hedged sentence

0.0540

closest p · 1.1× alpha

0.0540

boldest claim

The sentences

borderline significancep=0.054so close (0.05 < p ≤ 0.1)

Oligometastatic patients tended to have a lower incidence of EGFR 19del, with borderline significance (18.18% vs. 38.10%, p=0.054), while the missense mutations, EGFR L858R, had a comparable incidence between two series (23.38% vs. 19.05%, p=0.754) ( S4B Fig. ). 3.

also in 4,352 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.